Results 1 to 10 of about 281,787 (275)

Autoimmune Atrophic Gastritis: A Clinical Review. [PDF]

open access: yesCancers (Basel)
Autoimmune atrophic gastritis (AAG) is a chronic condition characterized by the presence of atrophy in the oxyntic mucosa due to anti-parietal cell antibodies. This review provides a comprehensive and up-to-date overview of autoimmune atrophic gastritis, reporting recent evidence on epidemiology, pathogenesis, diagnosis, clinical presentation, risk of ...
Castellana C   +8 more
europepmc   +5 more sources

Changes of gastric microflora and metabolites in patients with chronic atrophic gastritis [PDF]

open access: yesJournal of Translational Medicine
Background Chronic atrophic gastritis (CAG) is related to the body’s microbial and metabolic systems. Combined studies of microbiome and metabolomics can clarify the mechanisms of disease occurrence and progression.
Yumei Ma   +8 more
doaj   +2 more sources

The recognition of atrophic gastritis [PDF]

open access: greenJournal of British Surgery, 1969
John Kirkpatrick   +3 more
openalex   +4 more sources

Autoimmune atrophic gastritis: current perspectives

open access: yesClinical and Experimental Gastroenterology, 2017
Artem Minalyan,1 Jihane N Benhammou,1 Aida Artashesyan,1 Michael S Lewis,2 Joseph R Pisegna1 1Division of Gastroenterology, Hepatology and Parenteral Nutrition, 2Department of Pathology and Laboratory Medicine, VA Greater Los Angeles Healthcare System ...
Minalyan A   +4 more
doaj   +7 more sources

Significance of serological atrophic gastritis on proton pump inhibitor prescriptions and referrals to gastroscopy in the general population [PDF]

open access: yesJGH Open
Background and Aim We aimed to investigate whether individuals with low pepsinogen I levels differed from those with normal pepsinogen I levels in terms of proton pump inhibitors (PPIs) use, referral to gastroscopy, and findings on gastroscopy.
Tor Persson   +3 more
doaj   +2 more sources

Therapeutic regimens against infection without proton pump inhibitors in patients with corpus atrophic gastritis: a real-life single-centre longitudinal observational study [PDF]

open access: yesTherapeutic Advances in Gastroenterology
Background: Efficacy of eradication regimens in Helicobacter pylori (Hp) infection is commonly reported with proton pump inhibitors (PPIs). In patients with corpus atrophic gastritis, characterized by impaired acid secretion, PPI treatment is ...
Emanuele Dilaghi   +7 more
doaj   +2 more sources

RETROSPECTIVE ANALYSIS OF GASTRITIS ASSOCIATED WITH CHRONIC ATROPHIC H. PYLORI IN PATIENTS WITH NOCARDIAL GASTRIC CANCER IN BUKHARA CITY AND PREVENTION OF ATROPHIC PROCESSES OF GASTRIC MUCOSA

open access: yesInterdisciplinary Approaches to Medicine, 2022
Atrophic gastritis is understood as a progressive inflammatory process of the gastric mucosa, characterized by the loss of gastric glands. Helicobacter pylori infection (HP) and autoimmune gastritis are recognized as the most common etiological factors ...
Abdullaeva Umida Kurbanovna
doaj   +3 more sources

Atrophic gastritis: a related factor for osteoporosis in elderly women. [PDF]

open access: yesPLoS ONE, 2014
PURPOSE: Osteoporosis poses a great threat to the aging society. Hypochlorhydric or achlorhydric conditions are risk factors for osteoporosis. Atrophic gastritis also decreases gastric acid production; however, the role of atrophic gastritis as a related
Hye Won Kim   +8 more
doaj   +1 more source

Diagnostic Accuracy of EndoFaster® and Narrow-Band Imaging Endoscopy in Patients with Impaired Gastric Acid Secretion: A Real-Time Prospective Study

open access: yesGastroenterology Research and Practice, 2021
Background. EndoFaster® analyzes gastric juice in real time during gastroscopy allowing the detection of hypo-achlorhydric conditions, like corpus atrophic gastritis.
M. Cazzato   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy